Article
The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.
Archives of gynecology and obstetrics - 1 Nov 2014
Carlioglu Ayse, Kaygusuz Ikbal, Karakurt Feridun, Gumus Ilknur Inegol, Uysal Aysel, Kasapoglu Benan, Armutcu Ferah, Uysal Sema, Keskin Esra Aktepe, Koca Cemile
Abstract excerpt
PURPOSE: To evaluate the platelet activating factor acetyl hydrolyze (PAF-AH), oxidized low-density lipoprotein (ox-LDL), paraoxonase 1 (PON1), arylesterase (ARE) levels and the effects of metformin and Diane-35 (ethinyl oestradiol + cyproterone acetate) therapies on these parameters and to determine the PON1 polymorphisms among PCOS patients. METHODS: Ninety patients with PCOS, age 30, and body mass...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.